Related Experiment Video
Updated: May 22, 2026
12:24
Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
Drugging Wnt signalling in cancer
1Department of Molecular Oncology, Genentech Inc., South San Francisco, CA 94080, USA. ppolakis@gene.com
The EMBO Journal
|May 24, 2012
Summary
Aberrant Wnt signaling drives cancer. This chapter explores inhibiting this pathway for cancer therapy, covering proof-of-concept, methods, and recent advances in Wnt signaling inhibitors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling Pathways
Background:
- Aberrant regulation of the Wnt signaling pathway is a common feature in cancer development.
- The Wnt pathway plays a critical role in cell proliferation, differentiation, and survival.
Purpose of the Study:
- To provide a proof of concept for inhibiting Wnt signaling as a cancer treatment strategy.
- To outline potential therapeutic approaches and recent advancements in Wnt pathway inhibition.
- To discuss molecular diagnostics and safety considerations for Wnt-targeted therapies.
Main Methods:
- Review of existing research on Wnt signaling in cancer.
- Analysis of different strategies for Wnt pathway inhibition.
- Discussion of emerging therapeutic targets and agents.
Main Results:
- Demonstrated feasibility of targeting the Wnt pathway in preclinical and clinical settings.
- Identified several molecular mechanisms and drug candidates for Wnt inhibition.
- Highlighted the importance of diagnostic tools for patient selection and monitoring.
Conclusions:
- Inhibiting the Wnt signaling pathway holds significant therapeutic potential for various cancers.
- Further research and development are needed to optimize Wnt-targeted therapies and address safety concerns.
- Personalized approaches using molecular diagnostics will be crucial for effective Wnt-targeted cancer treatment.
More Related Videos
11:13Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:41Non-Canonical Wnt Signaling Pathways
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:26Signal Transduction: Overview
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...